Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-320,015
Closed -$8.37M 262
2024
Q2
$8.37M Sell
320,015
-36,227
-10% -$753K 0.5% 54
2024
Q1
$7.79M Sell
356,242
-12,752
-3% -$273K 0.44% 58
2023
Q4
$8.58M Sell
368,994
-6,425
-2% -$129K 0.5% 54
2023
Q3
$7.41M Sell
375,419
-7,625
-2% -$150K 0.47% 56
2023
Q2
$8.68M Sell
383,044
-2,253
-0.6% -$45.4K 0.49% 54
2023
Q1
$7.57M Sell
385,297
-26,904
-7% -$516K 0.43% 55
2022
Q4
$7.09M Buy
+412,201
New +$7.31M 0.41% 61

Other funds holding RXO

Rice Hall James & Associates's RXO Position: Q3 2024 in Review

Rice Hall James & Associates sold out of RXO (RXO) in Q3 2024, closing a stake of 320,015 shares — an estimated $8.37M sold.

Rice Hall James & Associates first reported a position in RXO in Q4 2022 and held it in 7 quarters. The position peaked at $8.68M in Q2 2023. 280 funds tracked by Wall St. Rank hold RXO as of Q3 2024.

  • Rice Hall James & Associates reported no remaining RXO position as of Q3 2024 after selling out during the quarter.
  • Rice Hall James & Associates sold 320,015 RXO shares in Q3 2024, an estimated $8.37M.
  • Rice Hall James & Associates first reported a position in RXO in Q4 2022 and held it in 7 quarters.
  • Rice Hall James & Associates's RXO position peaked at $8.68M in Q2 2023.
  • 280 funds tracked by Wall St. Rank held RXO as of Q3 2024.

Based on Rice Hall James & Associates's 13F filing for Q3 2024, filed 28 Oct 2024.